ARIVITY Trademark

Trademark Overview

On Friday, March 25, 2005, a trademark application was filed for ARIVITY with the United States Patent and Trademark Office. The USPTO has given the ARIVITY trademark a serial number of 78595542. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2009. This trademark is owned by Bristol-Myers Squibb & Gilead Sciences,LLC. The ARIVITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of infectious diseases, disorders and conditions; pulmonary diseases, disorders and conditions; and pulmonary hypertension
arivity

General Information

Serial Number78595542
Word MarkARIVITY
Filing DateFriday, March 25, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of infectious diseases, disorders and conditions; pulmonary diseases, disorders and conditions; and pulmonary hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 31, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb & Gilead Sciences,LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFoster City, CA 94404
Party NameBristol-Myers Squibb & Gilead Sciences,LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFoster City, CA 94404

Trademark Events

Event DateEvent Description
Monday, June 8, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 8, 2009ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 6, 2008EXTENSION 3 GRANTED
Thursday, November 6, 2008EXTENSION 3 FILED
Thursday, November 6, 2008TEAS EXTENSION RECEIVED
Wednesday, April 30, 2008EXTENSION 2 GRANTED
Wednesday, April 30, 2008EXTENSION 2 FILED
Wednesday, April 30, 2008TEAS EXTENSION RECEIVED
Thursday, November 8, 2007EXTENSION 1 GRANTED
Wednesday, October 24, 2007EXTENSION 1 FILED
Wednesday, October 24, 2007TEAS EXTENSION RECEIVED
Tuesday, May 8, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2007NOTICE OF PUBLICATION
Thursday, December 21, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 21, 2006ASSIGNED TO LIE
Wednesday, December 6, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 1, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 31, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 31, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 31, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 18, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 18, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 24, 2006FINAL REFUSAL MAILED
Tuesday, May 23, 2006FINAL REFUSAL WRITTEN
Thursday, April 27, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 20, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 21, 2005NON-FINAL ACTION MAILED
Thursday, October 20, 2005NON-FINAL ACTION WRITTEN
Wednesday, October 19, 2005ASSIGNED TO EXAMINER
Thursday, March 31, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

arivity disorders conditions pulmonary diseases hypertension infectious preparations human treatment pharmaceutical